BackgroundCheck.run
Search For

Megan S Mcafee, 36Wayland, MA

Known as:
Megan S Mcaf Megan Mc Afee
Related to:
Beth Griffiths

Megan Mcafee Phones & Addresses

Wayland, MA   

Seattle, WA   

Mercer Island, WA   

Chandler, AZ   

West Linn, OR   

Tualatin, OR   

Get Report
Control this profile

Mentions for Megan S Mcafee

Megan Mcafee resumes & CV records

Resumes

Megan Mcafee Photo 23

Scientist Ii

Location:
Seattle, WA
Work:
Takeda Pharmaceuticals
Scientist Ii
Education:
Arizona State University 2011 - 2015
Doctorates, Doctor of Philosophy, Philosophy
Megan Mcafee Photo 24

Megan Mcafee

Megan Mcafee Photo 25

Megan Mcafee

Skills:
Mcafee

Publications & IP owners

Us Patents

Merkel Cell Polyomavirus T Antigen-Specific Tcrs And Uses Thereof

US Patent:
2021025, Aug 19, 2021
Filed:
May 15, 2019
Appl. No.:
17/055969
Inventors:
- Seattle WA, US
Megan MCAFEE - Seattle WA, US
Natalie MILLER - Seattle WA, US
Kelly PAULSON - Shoreline WA, US
David KOELLE - Seattle WA, US
Thomas SCHMITT - Seattle WA, US
Candice CHURCH - Seattle WA, US
International Classification:
A61K 35/17
A61K 38/20
A61K 38/21
C12N 5/0783
Abstract:
The present disclosure provides binding proteins and TCRs with high affinity and specificity against Merkel cell polyomavirus T antigen epitopes or peptides, T cells expressing such high affinity Merkel cell polyomavirus T antigen specific TCRs, nucleic acids encoding the same, and compositions for use in treating Merkel cell carcinoma.

High Affinity Merkel Cell Polyomavirus T Antigen-Specific Tcrs And Uses Thereof

US Patent:
2020003, Jan 30, 2020
Filed:
Nov 14, 2017
Appl. No.:
16/348378
Inventors:
- Seattle WA, US
Megan S. McAfee - Seattle WA, US
Natalie J. Miller - Seattle WA, US
Kelly Garneski Paulson - Shoreline WA, US
David Martin Koelle - Seattle WA, US
Thomas M. Schmitt - Seattle WA, US
Candice Church - Seattle WA, US
International Classification:
A61K 35/17
C07K 14/725
C07K 16/28
Abstract:
The present disclosure provides binding proteins and TCRs with high affinity and specificity against Merkel cell Poly-omavirus T antigen epitopes or peptides, T cells expressing such high affinity Merkel cell polyomavirus T antigen specific TCRs, nucleic acids encoding the same, and compositions for use in treating Merkel cell carcinoma.

High Affinity Mage-A1-Specific Tcrs And Uses Thereof

US Patent:
2020001, Jan 16, 2020
Filed:
Sep 13, 2019
Appl. No.:
16/571013
Inventors:
- Seattle WA, US
Thomas SCHMITT - Seattle WA, US
Megan MCAFEE - Seattle WA, US
International Classification:
C07K 14/725
A61P 35/00
A61K 35/17
C07K 14/705
C12N 5/0783
Abstract:
The present disclosure provides TCRs with high or enhanced affinity against various tumor associated antigens (including human MAGE-A1 epitopes), T cells expressing such high affinity antigen-specific TCRs, nucleic acids encoding the same, and compositions for use in treating diseases or disorders in which cells overexpress one or more of these antigens, such as in cancer.

Possible Relatives

Cynthia Mcafee  David O Mcafee  Dawna M Mcafee  Deborah L Mcafee  Dana L Mcafee  Dena P Mcafee  Denise L Mcafee  Megan M Last  Megan J Johnson  Megan Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.